Cite
HARVARD Citation
Capdevila, J. et al. (2021). Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509). Journal of clinical oncology. 39 (20), pp. 2304-2312. [Online].